🔒 Premium: Both sides of two controversies – Banning of Ivermectin and SA Jewish Report

BizNews editor Michael Appel and I yesterday recorded the sixth episode of our A-Plus show (click here), where we offer commentary on the past week’s developments in business and politics. 

What we did not cover, however, is the divergence of opinion emerging on two controversies which deserve your attention. The reaction to George Cocolas’s attack on BN’s Ukrainian War position suggest our tribes loves being exposed to both sides of any argument. Please click on links below to access relevant reports. 


First up is the SA authorities’ banning of Ivermectin. This morning’s Business Day carries an editorial describing SAHPRA’s decision as “a blow against flawed science”. BizNews’s top story this morning, penned by UKZN Prof Colleen Aldous, takes the opposite view

Then there’s the unprecedented eviction of the SA Jewish Report from the SA Press Council. Both reports come from our friends at Politicsweb. Columnist Jeremy Gordin’s treatise provides the back story to the extraordinary action by the authority. Press Council exec Latiefa Mobara offers the other side’s perspective

I’m hoping to witness more commentary on these issues in the BizNews Premium Interactive WhatsApp channel. Good news: WhatsApp has just doubled the number of people who can join groups to 512. So we are able to re-open membership on the Interactive Channel. Only for Premium subscribers – click here to join.

More for you to read today: 


As a Premium subscriber you are entitled to full membership of wsj.com (normal price $29 a month). Be sure to action your access through the Premium link on the BizNews website. Because of The Wall Street Journal’s credential requirements, be sure to create a password which has at least 8 characters and includes at least one letter and one number – NB it MAY NOT contain any special characters (ie #, !, @ etc). To maintain access to WSJ.com, you MUST enter our partner’s website via Biznews Premium at least once a month. A final PS, if you had previously signed up for WSJ you’ll need to clear the cookies from your device. Our helpdesk can assist – [email protected]

Visited 144 times, 1 visit(s) today